A double-digit drop for Amgen (NASDAQ:AMGN) stock over the past couple of months has ... stage clinical studies that have the potential to do well. Is now a great time to buy Amgen stock? I think so. Keith began writing for the Fool in …
Cypress Capital Group acquired 7,178 shares as Amgen Inc (AMGN)’s stock declined 9.68%. The Cypress Capital …
Rating reiterations for Jan. 25 from Briefing.com: Company Symbol Brokerage Firm Reiterations Alaska Air ALK UBS Neutral Amgen AMGN Lehman Brothers Overweight Ariba ARBA Roth Capital Buy ArthroCare ARTC SMH Capital Buy …
YTD, Amgen’s (AMGN) stock has already fallen 9%. Perhaps the pressure on Enbrel (etanercept) is to blame for the negative investor sentiment. Receive e-mail alerts for new research on AMGN Success! You are now receiving e-mail …
The stock rose 0.08% or $0.14 reaching $173.46. About 224,195 shares traded. It has outperformed by 10.79% the S&P500. More notable recent Amgen, Inc. 6,000 Dynavax Technologies Corporation (NASDAQ:DVAX) shares with …
The broader large-cap biotech space as represented by the iShares Nasdaq Biotechnology Index (ETF) (NASDAQ:IBB) is also higher by around 18% for the year, which is to say that AMGN stock in terms of performance is trading just about …
It was an excellent quarter for the world’s largest biotechnology company, Amgen, Inc. (NASDAQ:AMGN), as it posted …
AMGN) and Eli Lilly and Co (NYSE:LLY). As a matter of fact, the stock market today is interesting especially looking at …
Shares of Amgen (AMGN) have been performing quite well this month. The stock is working on a string of seven straight higher lows and is beginning to pierce heavy supply near the April lows. This powerful reversal from the ugly action on …
Amgen, Inc. (NASDAQ: AMGN) Tuesday earnings report was of "poor-quality" and the company doesn't have any near-term catalysts to support the stock, analysts at BMO Capital Markets said. Analyst M. Ian Somaiya downgraded …